Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Berntorp

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Seminars in Thrombosis and Hemostasis|September 16, 2006
Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3Erik Berntorp
Thrombosis Research|December 1, 2009
Haemate P/Humate-P: a systematic reviewErik Berntorp
Pediatric Blood & Cancer|October 31, 2012
Von Willebrand diseaseErik Berntorp
Haematologica|June 27, 2003
Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?Erik Berntorp
Thrombosis Research|May 22, 2007
Erik von WillebrandErik Berntorp
European Journal of Haematology. Supplementum|June 25, 2014
Introduction. Outcome measures in haemophilia: a systematic reviewErik Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 17, 2019
Moderate haemophilia in focusErik Berntorp
Hamostaseologie|November 24, 2016
Plasma-derived versus recombinant factor concentrates in PUPs: a never ending debate?Erik Berntorp
Blood|April 20, 2023
Immune tolerance induction in developmentErik Berntorp
Thrombosis Research|March 15, 2006
The need for prophylaxis in von Willebrand's disease and other coagulation disordersAlison Street, Erik Berntorp
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Seminars in Thrombosis and Hemostasis|September 16, 2006
Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3Erik Berntorp
Thrombosis Research|December 1, 2009
Haemate P/Humate-P: a systematic reviewErik Berntorp
Pediatric Blood & Cancer|October 31, 2012
Von Willebrand diseaseErik Berntorp
Haematologica|June 27, 2003
Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?Erik Berntorp
Thrombosis Research|May 22, 2007
Erik von WillebrandErik Berntorp
European Journal of Haematology. Supplementum|June 25, 2014
Introduction. Outcome measures in haemophilia: a systematic reviewErik Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 17, 2019
Moderate haemophilia in focusErik Berntorp
Hamostaseologie|November 24, 2016
Plasma-derived versus recombinant factor concentrates in PUPs: a never ending debate?Erik Berntorp
Blood|April 20, 2023
Immune tolerance induction in developmentErik Berntorp
Thrombosis Research|March 15, 2006
The need for prophylaxis in von Willebrand's disease and other coagulation disordersAlison Street, Erik Berntorp
Pageof 14